These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25422422)

  • 1. Mechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activity.
    Chen H; Beardsley GP; Coen DM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17462-7. PubMed ID: 25422422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
    Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.
    Chou S; Marousek G; Bowlin TL
    Antimicrob Agents Chemother; 2012 Jan; 56(1):197-201. PubMed ID: 21968367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of cytomegalovirus UL54 exonuclease domain mutations on acyclovir and cidofovir susceptibility.
    Chou S
    Antiviral Res; 2021 Nov; 195():105181. PubMed ID: 34560144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains.
    Kariya M; Mori S; Eizuru Y
    Antiviral Res; 2000 Feb; 45(2):115-22. PubMed ID: 10809020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exonuclease-polymerase active site partitioning of primer-template DNA strands and equilibrium Mg2+ binding properties of bacteriophage T4 DNA polymerase.
    Beechem JM; Otto MR; Bloom LB; Eritja R; Reha-Krantz LJ; Goodman MF
    Biochemistry; 1998 Jul; 37(28):10144-55. PubMed ID: 9665720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase.
    Chen H; Li C; Zemlicka J; Gentry BG; Bowlin TL; Coen DM
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4176-82. PubMed ID: 27139481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of ganciclovir-resistant cytomegalovirus].
    Eizuru Y
    Nihon Rinsho; 1998 Jan; 56(1):151-5. PubMed ID: 9465681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the 3'- to 5'-exonuclease activity of herpes simplex virus type 1 DNA polymerase to the fidelity of DNA synthesis.
    Song L; Chaudhuri M; Knopf CW; Parris DS
    J Biol Chem; 2004 Apr; 279(18):18535-43. PubMed ID: 14982924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
    Scott GM; Weinberg A; Rawlinson WD; Chou S
    Antimicrob Agents Chemother; 2007 Jan; 51(1):89-94. PubMed ID: 17043128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.
    Ruiz-Carrascoso G; Romero-Gómez MP; Plaza D; Mingorance J
    J Med Virol; 2013 Jul; 85(7):1250-7. PubMed ID: 23592041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
    Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
    J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase.
    Mousavi-Jazi M; Schloss L; Wahren B; Brytting M
    J Clin Virol; 2003 Apr; 26(3):301-6. PubMed ID: 12637079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
    Bounaadja L; Piret J; Goyette N; Boivin G
    J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
    Isegawa Y; Hara J; Amo K; Osugi Y; Takemoto M; Yamanishi K; Fukunaga R; Shibata M; Ohshima A; Horiguchi Y; Sugimoto N
    J Clin Virol; 2009 Jan; 44(1):15-9. PubMed ID: 18952495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
    Göhring K; Mikeler E; Jahn G; Rohde F; Hamprecht K
    Antivir Ther; 2008; 13(3):461-6. PubMed ID: 18572760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
    Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
    Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
    J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.